Keynote Speakers

Kari Alitalo, Haartman Institute, Helsingin Yliopisto, Finland
Chi Van Dang, Abramson Cancer Center, University of Pennsylvania, USA

Confirmed Speakers

Peter Carmeliet, VIB & Katholieke Universiteit Leuven, Belgium
Gabriele Bergers, Department of Neurological Surgery, University of California, San Francisco, USA
Stefanie Dimmeler, Institute for Cardiovascular Regeneration, Goethe-University Frankfurt am Main, Germany
Ralph DeBerardinis, University of Texas - Southwestern Medical Center at Dallas, USA
Michele De Palma, Institut Suisse de Recherche Experimentale sur le Cancer (ISREC), Switzerland
Napoleone Ferrara, Genentech, USA
Holger Gerhardt, Cancer Research UK, London Research Institute, UK & VIB, Belgium
Douglas Hanahan, Institut Suisse de Recherche Experimentale sur le Cancer (ISREC), Switzerland
Adrian Harris, Weatherall Institute of Molecular Medicine, University of Oxford, UK
Timothy Hla, Center for Vascular Biology, Weill Medical College, Cornell University, USA
Luisa Iruela-Arispe, Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, USA
Joseph Loscalzo, Department of Medicine, Harvard Medical School & Brigham and Women's Hospital, Boston, USA
Salvador Moncada, University College London, UK & VIB, Belgium
Michael Potente, Institute for Cardiovascular Regeneration, Goethe-University Frankfurt am Main, Germany
Gregg Semenza, Department of Pediatrics, Medicine, Oncology, and Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, USA
M. Celeste Simon, Abramson Family Cancer Research Institute, University of Pennsylvania, USA
Inder Verma, Laboratory of Genetics, The Salk Institute for Biological Studies, La Jolla, USA
Karen Vousden, The Beatson Institute for Cancer Research, Glasgow, UK